Neurotransmisión y neurorreparación
Universitat de Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Universitat de Barcelona (16)
2023
-
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
Nature Communications, Vol. 14, Núm. 1
-
Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121
2022
-
Relationship between immunometabolic status and cognitive performance among major depression disorder patients
Psychoneuroendocrinology, Vol. 137
2021
-
Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941
2018
-
Identification of a Tool Compound to Study the Mechanisms of Functional Selectivity between D2 and D3 Dopamine Receptors
ACS Omega, Vol. 3, Núm. 12, pp. 17368-17375
2016
-
Role of Mitochondrial Complex IV in Age-Dependent Obesity
Cell Reports, Vol. 16, Núm. 11, pp. 2991-3002
2014
-
Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: Role of Asn181 and Ile335 validated by spectroscopic and computational studies
Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1844, Núm. 2, pp. 389-397
-
Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: Design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids
Drug Design, Development and Therapy, Vol. 8, pp. 1893-1910
2011
-
Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease
Journal of Medicinal Chemistry, Vol. 54, Núm. 24, pp. 8251-8270
2010
-
The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals
Journal of Biological Chemistry, Vol. 285, Núm. 23, pp. 17907-17917
2009
-
Subcellular compartment-specific molecular diversity of pre- and post-synaptic GABAB-activated GIRK channels in Purkinje cells
Journal of Neurochemistry, Vol. 110, Núm. 4, pp. 1363-1376
-
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease
Journal of Medicinal Chemistry, Vol. 52, Núm. 9, pp. 2724-2732
2008
-
Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5- benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells
Journal of Neurochemistry, Vol. 105, Núm. 6, pp. 2404-2417
-
New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties
Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 16, pp. 7759-7769
2007
-
The coexistence of multiple receptors in a single nerve terminal provides evidence for pre-synaptic integration
Journal of Neurochemistry, Vol. 103, Núm. 6, pp. 2314-2326
2004
-
Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/ butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors
Bioorganic and Medicinal Chemistry, Vol. 12, Núm. 9, pp. 2199-2218